SynapDx's Series C Round

SynapDx raised a round of funding on July 22, 2013.

SynapDx is an early stage laboratory services company developing a blood based test to enable earlier detection of Autism Spectrum Disorders (ASDs). ASDs are characterized by impairment in language an…

Articles about SynapDx's Series C Round: